Identification of biologically relevant subtypes of hidradenitis suppurativa

化脓性汗腺炎生物学相关亚型的鉴定

基本信息

  • 批准号:
    10643831
  • 负责人:
  • 金额:
    $ 8.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Hidradenitis suppurativa (HS) is a neglected, prevalent, chronic, stigmatizing, and debilitating disease that has recently been prioritized for study by NIAMS. Evidence suggests that some HS patients choose to self-manage symptoms remaining unconnected to healthcare, and some seek medical care for repeated outbreaks of boils but never receive a diagnosis. Such ‘hidden populations’ create challenges for designing research studies that are generalizable. Precision medicine initiatives and resources offer opportunities to rapidly increase our knowledge about biological causes of HS and to improve the care that HS patients receive. For example, the NIH has made considerable investments in the development of data repositories that link genetic data to EHR for hundreds of thousands of patients, including the NHGRI-funded eMERGE Network and the NIH-funded All of Us Research Program. Columbia University investigators are integral members of these nationwide programs, both as a recruitment site, as well as a data and research center (5U01HG008680, 1OT2OD026556). Engaging research participants who are willing to contribute longitudinal data is a major obstacle to precision medicine initiatives. The public’s use of the Internet and social media to obtain and exchange health-related information has created opportunities to rapidly and efficiently assemble large longitudinal cohorts, yet there are important differences from traditional research methods and best practice guidelines have yet to be developed. Columbia University is at the forefront of the development and application of these methods. A major challenge to implementing precision medicine arises from patients who share a diagnosis but have different biological causes of disease. HS patients have a high burden of comorbidities and we hypothesize that sets of comorbidities that tend to present together in individual patients can be used to identify biologically relevant disease subtypes. Here we will use three approaches to identify patterns of comorbidities within patients, to characterize the generalizability of the results from studies conducted in EHR, and to use genetic data to biologically validate comorbidities and resolve causality underlying disease associations. Training in biomedical informatics and Internet-based survey research will allow the applicant to use EHR data and Internet resources for assembling cohorts to conduct these studies, and complement her previous training in epidemiology, biostatistics, molecular biology and human genetics, providing fluency across several domains that are crucial for advancing precision medicine initiatives. Completion of this proposal will achieve the applicant’s long-term goal of obtaining advanced training aimed at implementing precision medicine in the treatment of skin disease.
项目摘要 Hidradenenitis purrativa(HS)是一种被忽视的,普遍的,慢性的,污名化的,具有衰弱的疾病 最近,NIAMS优先考虑研究。有证据表明一些HS患者选择自我管理 与医疗保健无关的症状,有些人寻求医疗保健 但永远不会收到诊断。这种“隐藏人口”为设计研究带来了挑战, 是可以推广的。精密医学计划和资源提供了迅速增加我们的机会 有关HS生物学原因的知识,并改善HS患者接受的护理。例如, NIH已考虑将遗传数据与EHR联系起来的数据存储库的开发 成千上万的患者,包括NHGRI资助的Emerge网络和NIH资助的所有患者 美国研究计划。哥伦比亚大学的调查人员是这些全国计划的组成部分, 既作为招聘站点,又是数据和研究中心(5U01HG008680,1OT2OD026556)。参与 愿意贡献纵向数据的研究参与者是精密医学的主要障碍 倡议。公众使用互联网和社交媒体来获取和交换与健康相关的信息 已经创造了快速有效地组装大型纵向人群的机会,但是有重要的 尚未制定与传统研究方法和最佳实践指南的差异。哥伦比亚 大学处于这些方法开发和应用的最前沿。对 实施精确药物是由共享诊断但有不同生物学原因的患者产生的 疾病。 HS患者的合并症很高,我们假设合并症集 倾向于在个别患者中共同呈现,可用于鉴定与生物学相关的疾病亚型。这里 我们将使用三种方法来识别患者内合并症的模式,以表征 在EHR中进行的研究结果的概括性,并使用遗传数据在生物学上验证 合并症和解决疾病关联的偶然性。生物医学信息培训和 基于互联网的调查研究将使申请人使用EHR数据和互联网资源来组装 进行这些研究,并补充她先前在流行病学,生物统计学,分子方面的培训 生物学和人类遗传学,在几个领域中提供流利性,这些领域对于提高精度至关重要 医学计划。该提案的完成将实现申请人的长期目标,即获得高级 旨在在治疗皮肤病方面实施精确医学的培训。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
International Classification of Diseases codes do not capture all cases of hidradenitis suppurativa in the electronic health record: a retrospective cohort.
  • DOI:
    10.1111/bjd.21695
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    10.3
  • 作者:
    Bonds, Pauleatha Diggs;Huang, Joyce;Ike, Jacqueline;Mukherjee, Eric;Petukhova, Lynn;Wheless, Lee
  • 通讯作者:
    Wheless, Lee
Clinical translation of hidradenitis suppurativa genetic studies requires global collaboration.
  • DOI:
    10.1111/bjd.20749
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Jabbour AJ;van Straalen KR;Colvin A;Prens EP;Petukhova L
  • 通讯作者:
    Petukhova L
Who has skin in the game? Expanding patient opportunities for research engagement is a win-win for dermatology.
谁在游戏中拥有利益?
  • DOI:
    10.1093/bjd/ljad394
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Colvin,Annelise;Petukhova,Lynn
  • 通讯作者:
    Petukhova,Lynn
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lynn Petukhova其他文献

Lynn Petukhova的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lynn Petukhova', 18)}}的其他基金

Establishing the contributions of monogenic etiologies to hidradenitis suppurativapathogenesis
确定单基因病因对化脓性汗腺炎发病机制的贡献
  • 批准号:
    10595266
  • 财政年份:
    2023
  • 资助金额:
    $ 8.67万
  • 项目类别:
Identification of biologically relevant subtypes of hidradenitis suppurativa
化脓性汗腺炎生物学相关亚型的鉴定
  • 批准号:
    10405535
  • 财政年份:
    2020
  • 资助金额:
    $ 8.67万
  • 项目类别:
Identification of biologically relevant subtypes of hidradenitis suppurativa
化脓性汗腺炎生物学相关亚型的鉴定
  • 批准号:
    9977561
  • 财政年份:
    2020
  • 资助金额:
    $ 8.67万
  • 项目类别:
Identification of biologically relevant subtypes of hidradenitis suppurativa
化脓性汗腺炎生物学相关亚型的鉴定
  • 批准号:
    10160823
  • 财政年份:
    2020
  • 资助金额:
    $ 8.67万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Appalachian Tobacco Regulatory Science Team (AppalTRuST)
阿巴拉契亚烟草监管科学团队 (AppalTRuST)
  • 批准号:
    10665319
  • 财政年份:
    2023
  • 资助金额:
    $ 8.67万
  • 项目类别:
Marketing Monitoring Core (MMC)
营销监控核心 (MMC)
  • 批准号:
    10666074
  • 财政年份:
    2023
  • 资助金额:
    $ 8.67万
  • 项目类别:
The Unvarnished Truth: Pursuing Health Equity by Correcting Disinformation Targeting African Americans about the FDA's Proposed Ban on Menthol Cigarettes and Flavored Cigars
赤裸裸的真相:通过纠正针对非裔美国人的关于 FDA 提议禁止薄荷卷烟和调味雪茄的虚假信息来追求健康公平
  • 批准号:
    10740281
  • 财政年份:
    2023
  • 资助金额:
    $ 8.67万
  • 项目类别:
Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and Retail
国家抢先实施地方烟草控制立法对烟草使用、接触和零售差异的影响
  • 批准号:
    10681733
  • 财政年份:
    2023
  • 资助金额:
    $ 8.67万
  • 项目类别:
Effects of Nicotine Concentration Levels in E-cigarettes on Biomarkers of Exposure to Toxicants and Tobacco Use Behaviors
电子烟中尼古丁浓度水平对有毒物质暴露和烟草使用行为生物标志物的影响
  • 批准号:
    10678555
  • 财政年份:
    2023
  • 资助金额:
    $ 8.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了